Ian Curley

35 results

Kymab’s main product is a potential treatment for eczema that is going through clinical trials. Photograph: iStock

One of Dublin-listed life science investment company Malin’s key holdings has signalled it plans to float on the stock market in the US. Biopharmaceu(...)

Ian Curley is a veteran of both Ardagh and Smurfit Kappa. Photograph: Dara Mac Dónaill

Life sciences investment company Malin’s chairman of less than a year, Ian Curley, has signalled that he plans to step down from the board as the busi(...)

Dublin-listed  company Malin says several of its assets have important milestones this year

Dublin-listed life sciences investment firm Malin had assets worth €404 million at the end of last year, according its latest annual results. The com(...)

Malin has recently had a board and management overhaul and is now headed by Ian Curley. Photograph:  Dara Mac Donaill

Life sciences investment firm Malin Corporation, which has seen its share price tumble as much as 60 per cent since its 2015 flotation, has pledged to(...)

Ian Curley and other executives are  due to present details of the group’s review at a capital markets day in London early next month

Dublin-listed life sciences investment firm Malin has announced the departure of chief executive Adrian Howd after just one year in the post. The tro(...)

Can Ian Curley save the day at Malin? Photograph: Dara Mac Dónaill

Call it a case of shareholder activism that couldn’t be bothered with the sea view. State-backed life sciences investment firm Malin Corporation’s an(...)

Malin chairman Ian Curley and non-executive director Liam Daniel at the company’s agm in Dún Laoghaire, Co Dublin. Photograph: Dara Mac Dónaill

Malin Corporation has bowed to shareholder pressure to review its executive pay plan, after it was rejected by almost 51 per cent of shareholders that(...)

Ian Curley (right) was appointed chairman of Malin in July.

Dublin-based life sciences investment firm Malin said the value of its investment portfolio rose to €402 million in the six months to June 30th. The (...)

Kelly Martin, former chief executive of Elan and co-founder of Malin. He left Malin in October last year, receiving a €3.2m exit settlement, compared to the €6.5m to which he was entitled.

Shareholders in Malin Corporation, the Dublin-based life sciences investment firm that’s reviewing its strategy in the wake of a share price slump and(...)

Ian Curley (right) previously served as chief financial officer of Smurfit Kappa Group, a FTSE 100 company.

Irish-based life sciences Malin has announced details of a boardroom shake-up, as well as an “extensive review” of the company’s portfolio and develop(...)

  • 1
  • 2
  • 3
  • 4
  • Next
  • Last »